Potential methods in unexplained infertility include oral
ovarian stimulation agents (such as
clomifene citrate,
anastrozole or
letrozole) as well as
intrauterine insemination (IUI),
intracervical insemination (ICI) and
in vitro fertilization (IVF). In women who have not had previous treatment, ovarian stimulation combined with IUI achieves approximately the same
live birth rate as IVF. On the other hand, in women who have had previous unsuccessful treatment, IVF achieves a live birth rate approximately 2–3 times greater than ovarian stimulation combined with IUI. According to
NICE guidelines, oral ovarian stimulation agents should
not be given to women with unexplained infertility. Rather, it is recommended that in vitro fertilization should be offered to women with unexplained infertility when they have not conceived after two years of regular unprotected sexual intercourse. IVF avails for
embryo transfer of the appropriate number of embryos to give good chances of pregnancy with minimal risk of multiple birth. A review of randomized studies came to the result that IVF in couples with a high chance of natural conception, as compared to IUI/ICI with or without ovarian stimulation, was
more effective in three studies and
less effective in two studies. There is no evidence for an increased risk of
ovarian hyperstimulation syndrome (OHSS) with IVF when compared with ovarian stimulation combined with IUI. ==Prognosis==